Scenarios that move FULC
Fulcrum Therapeutics, Inc. - Common Stock
Scenarios that move FULC: 1 analysis, 0 positive, 1 negative.
- · Satellos wins FDA IND clearance for Forazapadin in FSHD — ▼ · impact -41 · confidence medium · horizon immediate
Fulcrum Therapeutics, Inc. - Common Stock
Scenarios that move FULC: 1 analysis, 0 positive, 1 negative.